// App-Quantinova.ai

TCT-309 : Incidence and Clinical Impact of Major Infections Following PCI or CABG for Left Main Disease: Insights From the EXCEL Trial

Researchers

Presenter

  • Rodrigo Modolo

Principal Investigators

  • Gregg Stone

  • David Kandzari

  • David Taggart

  • Marie-Claude Morice

  • Dimitri Karmpaliotis

  • William Brown

  • Ply Chichareon

  • Norihiro Kogame

  • Ovidiu Dressler

  • Yoshinobu Onuma

  • A. Pieter Kappetein

  • Joseph Sabik

  • Patrick Serruys

Medical Centers

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • CERC, Massy, France

  • Cardiovascular Research Foundation, New York, New York, USA

  • New York–Presbyterian Hospital/Columbia University Medical Center, New York, New York

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Piedmont Heart Institute CardioThoracic Surgeons, Atlanta, Georgia

  • Imperial College, London, United Kingdom

  • Cardiovascular Research Foundation, Columbia University Medical Center/New York–Presbyterian Hospital, New York, New York

  • Piedmont Heart Institute, Atlanta, Georgia

  • Oxford University, Oxford, United Kingdom

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio

Locations

  • Netherlands

  • United Kingdom

  • United States

  • Georgia

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Left main disease

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final